Dr. Manpreet Singh Bhandal, MBBS, MD

Dr. Bhandal practices at Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium.

Dr. Bhandal's NPI, 1326351420, was assigned on July 17, 2010. Dr. Bhandal holds Texas license BP1-0037482.

Dr. Bhandal's primary practice is Alaska Native Medical Center, at 4315 Diplomacy Dr, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 563-2662.

Dr. Bhandal's primary practice is Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. Bhandal to 1 more group practice or clinic, named with a free account. Dr. Bhandal's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhandal practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bhandal's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Bhandal is licensed in Texas.

CMS data shows 410 Medicare services from Dr. Bhandal across 7 procedure codes in 2024, for 184 Medicare patients. Medicare paid $43,724 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 184 Medicare patients who saw Dr. Bhandal in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 54% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhandal's median patient age at 74, with 43% women.

In 2024, Dr. Bhandal wrote 917 Medicare Part D claims for 110 patients. 76% of them were for generic drugs. CMS names the drug for 700 of them, across 21 drugs with 11 or more claims each, at $85,709 in total drug cost. In 2023, CMS named 491 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bhandal for performance year 2024, reported as part of a group. Dr. Bhandal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhandal as offering telehealth.

CMS Open Payments shows 8 general payments to Dr. Bhandal from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Baxter Healthcare paid the most, $170.